Resurgence of Pediatric Tuberculosis in India

Article Sidebar

PDF
Published Oct 28, 2025
DOI: https://doi.org/10.18103/mra.v13i10.7001

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

Dr C. K. Sasidharan
Senior Consultant & Former Professor (Calicut Medical College) of Paediatrics; Baby Memorial Hospital', Calicut
Dr Swetha B Ram
Resident, Dept of Paediatrics; Baby Memorial Hospital, Calicut
Dr Athira Sasidharan
Associate professor; Dept of pathology; KMCT Medical College, Calicut
Dr Hareesh Thanikachalam
Resident, Dept of Paediatrics; Baby Memorial Hospital, Calicut

Abstract

The post-COVID-19 era has witnessed a resurgence of pediatric tuberculosis (TB) in India, highlighting its continued status as an important public health challenge. This review aims to analyse this resurgence, associated diagnostic challenges, recent advancements in detection methods, and strategies for effective management and prevention. It places particular emphasis on clinical presentations, the role of molecular diagnostics, and national programs  towards TB elimination.


Aims and Scope: The objective of this article is to analyze the burden, clinical spectrum, diagnostic tools, and treatment protocols of pediatric tuberculosis in India. The scope includes an overview of epidemiology, methodology of diagnostic strategies, and national policies with emphasis on future directions for tuberculosis elimination.

Article Details

How to Cite
SASIDHARAN, Dr C. K. et al. Resurgence of Pediatric Tuberculosis in India. Medical Research Archives, [S.l.], v. 13, n. 10, oct. 2025. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/7001>. Date accessed: 05 dec. 2025. doi: https://doi.org/10.18103/mra.v13i10.7001.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 13 No 10 (2025): Vol.13, Issue 10, October 2025
Section
Research Articles

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. Finlayson H, Lishman J, Palmer M. What's new in childhood tuberculosis. Curr Opin Pediatr. 2023;35 (2):166-175. doi:10.1097/MOP.0000000000001226

2. Swaminathan S, Rekha B. Pediatric tuberculosis: Global overview and challenges. Clin Infect Dis. 2010; 50(Suppl 3):S184-S194. doi:10.1086/651490

3. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis. 2004; 8(5):636-647.

4. Central TB Division. Nikshay Data from National Tuberculosis Elimination Program. Ministry of Health and Family Welfare, Government of India; 2021.

5. Central TB Division. India TB Report 2020. National Tuberculosis Elimination Program Annual Report. New Delhi: Ministry of Health and Family Welfare, Government of India; 2020.

6. Sharma SK, Mohan A, Kohli M. Extrapulmonary tuberculosis. Expert Rev Respir Med. 2021;15(7): 931-948.

7. Lin F. Tuberculous meningitis diagnosis and treatment: classic approaches and high-throughput pathways. Front Immunol. 2024;15:1543009.

8. Hemanth Kumar AK, Kumar A, Kannan T, et al. Pharmaco-kinetics of second-line Ministry of Health and Family Welfare, New Delhi, India, Cen-tral TB Division. Pediatric Tuberculosis Management Guideline 2022. RNTCP 2022. Available at: https://theindia.mobfw.gov.in/pediatric-th/ Accessed Apr 5, 2025

9. Seddon JA, Hesseling AC, Marais BJ, et al. Paediatric use of second-line anti-tuberculosis agents: A review. Tuberculosis. 2012:92:9-17.

10. Thee S, Seifart HL, Rosenkranz B, et al. Pharmacokinetics of ethionamide in children. Antimicrob Agents Chemother 2011:55-4594-600.

11. Chien 5, Wells TG, Blumer J., et al. Levofloxacin pharmacoki netics in children. J Clin Pharmacol. 2005,45:153-60.